author-photo

Joseph C. Marini

Janssen Pharmaceutica

25

Papers

650

Citations

Citation Trend

Filter By

Papers (18) Sort By

Journal Conference Others

Comparison of immunoassays for measuring serum levels of golimumab and antibodies against golimumab in ulcerative colitis

2019 Therapeutic Drug Monitoring
Show All
- Source
- Cite
- Save
Citations (7)
Immunogenicity of Guselkumab Is Not Clinically Relevant in Patients with Moderate-to-Severe Plaque Psoriasis

2019 Journal of Investigative Dermatology
Show All
- Source
- Cite
- Save
Citations (11)
2018 White Paper on Recent Issues in Bioanalysis: focus on flow cytometry, gene therapy, cut points and key clarifications on BAV (Part 3 – LBA/cell-based assays: immunogenicity, biomarkers and PK assays)

2018 Bioanalysis
Show All
- Source
- Cite
- Save
Citations (27)
Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.

2017 Aaps Journal
Show All
- Source
- Cite
- Save
Citations (36)
P226 Comparison of four different immunoassays for measuring golimumab and anti-golimumab antibody concentration in patients with ulcerative colitis

2017 Journal of Crohns & Colitis
Show All
- Source
- Cite
- Save
Citations (2)
Implementing a tiered approach to bioanalytical method validation for large-molecule ligand-binding assay methods in pharmacokinetic assessments

2017 Bioanalysis
Show All
- Source
- Cite
- Save
Citations (2)
Tiered Approaches to Chromatographic Bioanalytical Method Performance Evaluation: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team

2015 Aaps Journal
Show All
- Source
- Cite
- Save
Citations (15)
Comparison of Commercially Available Assays for Infliximab Concentrations and Antibodies to Infliximab With Assays Developed at Janssen and Used in Clinical Studies of Remicade (R) : Iinfliximab in IBD Patients

2015 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of Commercially Available Assays for Infliximab Concentrations and Antibodies to Infliximab With Assays Developed at Janssen and Used in Clinical Studies of Remicade®: Iinfliximab in IBD Patients Presidential Poster: 1853

2015 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Systematic Verification of Bioanalytical Similarity Between a Biosimilar and a Reference Biotherapeutic: Committee Recommendations for the Development and Validation of a Single Ligand-Binding Assay to Support Pharmacokinetic Assessments

2014 Aaps Journal
Show All
- Source
- Cite
- Save
Citations (15)